Homeopathic Claims Pose Continuing FTC/FDA Regulatory Conflict
This article was originally published in The Rose Sheet
Executive Summary
FTC shuts down the second marketer this year for making fraudulent claims for human chorionic gonadotropin weight-loss products. Enforcing against other homeopathics’ claims that violate advertising regulations, however, is on hold until FTC resolves its differences with FDA’s oversight of the category.